Impact of Home Intraocular Pressure Telemonitoring on Intraocular Pressure Control and Glaucoma Progression

Launched by THE UNIVERSITY OF HONG KONG · Jul 4, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how home monitoring of eye pressure (intraocular pressure or IOP) can help people with glaucoma better manage their condition. Participants will be divided into two groups: one group will use a special device at home to regularly check their eye pressure and send the results to their doctor, while the second group will receive standard treatment without the home monitoring. The goal is to see if those who monitor their eye pressure at home have lower eye pressure levels and experience less damage to the optic nerve over time.

To be eligible for this trial, participants should be newly diagnosed with primary open-angle glaucoma and have a certain level of vision. They will need to measure their eye pressure at home several times a week and upload the results, while those in the other group will receive medication for their condition. This study aims to provide better insights into managing glaucoma and could lead to improved care for patients in the future. It’s important to note that the trial is not yet recruiting participants, so there will be more details available when it begins.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Newly diagnosed primary open-angle glaucoma (POAG)
• • Best corrected visual acuity (VA) ≥20/40 for the included eye(s)
• Exclusion Criteria:
• • IOP \>35 millimeters of mercury (mmHg)
• • Dry eye syndrome
• • Central corneal thickness \<500μm or \>600μm
• • Failure to complete the iCare Home certification procedure at the baseline visits
• • Only one eye with functional vision
• • Inability to perform reliable visual field (VF)
• • Pathological myopia (eyes with axial length≥26mm with lacquer cracks and chorioretinal atrophy)
• • Suboptimal quality of optical coherence tomography (OCT) images (described below in RNFL imaging)
• • Previous intraocular surgery or corneal refractive surgery other than uncomplicated cataract extraction
• • Diabetic retinopathy/maculopathy